Radosław Krzemieniecki

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Dna Methylation

Top Venues

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Anoop Kallingal, Radosław Krzemieniecki, Natalia Maciejewska, Wioletta Brankiewicz, Maciej Bagiński
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy. Journal of cancer research and clinical oncology 150 (7) (2024)
Nicolò Tonali, Loreen Hericks, David C Schröder, Oliver Kracker, Radosław Krzemieniecki, Julia Kaffy, Vadim Le Joncour, Pirjo Laakkonen, Antoine Marion, Sandrine Ongeri, Veronica Isabel Dodero, Norbert Sewald
Peptidotriazolamers Inhibit Aβ(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem 86 (6) (2021)